Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction (Q46841580)

25 December 2017

title

Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction (English)

1 reference

25 December 2017

0 references

6

1 reference

25 December 2017

author name string

Wheatcroft J

1

1 reference

25 December 2017

Wakelin D

2

1 reference

25 December 2017

Smith A

3

1 reference

25 December 2017

Mahoney CR

4

1 reference

25 December 2017

Mawe G

5

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

Neurogastroenterology and Motility

published in

1 reference

25 December 2017

volume

17

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

863-870

1 reference

25 December 2017

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Evolving pathophysiologic models of functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Mucosal T cells regulate Paneth and intermediate cell numbers in the small intestine of T. spiralis-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2982.2005.00719.X

10.1111/J.1365-2982.2005.00719.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017